Lineage Cell: Q2 Earnings Snapshot

Audio By Carbonatix

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported a loss of $5.8 million in its second quarter.

On a per-share basis, the Carlsbad, California-based company said it had a loss of 3 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 4 cents per share.

The biotechnology company posted revenue of $1.4 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX